ZNF543
gene geneOn this page
Also known as DKFZp434H055
Summary
ZNF543 (zinc finger protein 543, HGNC:25281) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 543 (Q08ER8). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 125919 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 133 total
- MANE Select transcript:
NM_213598
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25281 |
| Approved symbol | ZNF543 |
| Name | zinc finger protein 543 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp434H055 |
| Ensembl gene | ENSG00000178229 |
| Ensembl biotype | protein_coding |
| OMIM | 616847 |
| Entrez | 125919 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000321545, ENST00000869765
RefSeq mRNA: 1 — MANE Select: NM_213598
NM_213598
CCDS: CCDS33130
Canonical transcript exons
ENST00000321545 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001223282 | 57326633 | 57326728 |
| ENSE00001317786 | 57327704 | 57330770 |
| ENSE00001415530 | 57320472 | 57320871 |
| ENSE00002437212 | 57323682 | 57323808 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 83.20.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.2629 / max 57.2208, expressed in 1707 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177766 | 6.1063 | 1705 |
| 177767 | 0.1566 | 72 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.20 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.75 | gold quality |
| cortical plate | UBERON:0005343 | 76.08 | gold quality |
| ventricular zone | UBERON:0003053 | 75.78 | gold quality |
| adrenal tissue | UBERON:0018303 | 75.05 | gold quality |
| ganglionic eminence | UBERON:0004023 | 74.70 | gold quality |
| calcaneal tendon | UBERON:0003701 | 73.57 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 73.22 | gold quality |
| corpus callosum | UBERON:0002336 | 72.04 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.80 | gold quality |
| islet of Langerhans | UBERON:0000006 | 71.67 | gold quality |
| muscle tissue | UBERON:0002385 | 71.23 | gold quality |
| tonsil | UBERON:0002372 | 69.43 | gold quality |
| placenta | UBERON:0001987 | 69.32 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 68.61 | gold quality |
| muscle of leg | UBERON:0001383 | 68.50 | gold quality |
| lymph node | UBERON:0000029 | 68.36 | gold quality |
| gastrocnemius | UBERON:0001388 | 68.15 | gold quality |
| endometrium | UBERON:0001295 | 68.07 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 68.07 | gold quality |
| bone marrow cell | CL:0002092 | 67.94 | silver quality |
| urinary bladder | UBERON:0001255 | 67.69 | gold quality |
| ovary | UBERON:0000992 | 67.21 | gold quality |
| left ovary | UBERON:0002119 | 66.81 | gold quality |
| adrenal gland | UBERON:0002369 | 66.41 | gold quality |
| bone marrow | UBERON:0002371 | 66.35 | gold quality |
| skin of leg | UBERON:0001511 | 66.23 | gold quality |
| zone of skin | UBERON:0000014 | 66.03 | gold quality |
| esophagus mucosa | UBERON:0002469 | 65.79 | gold quality |
| right ovary | UBERON:0002118 | 65.54 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
86 targeting ZNF543, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-3682-5P | 99.93 | 67.97 | 1163 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
Literature-anchored findings (GeneRIF, showing 2)
- Data indicate 3 variants in 3 novel genes myc target 1 protein (MYCT1), caspase recruitment domain family member 8 (CARD8) and zinc finger protein 543 (ZNF543), associated with familial IgA nephropathy (IgAN). (PMID:26095808)
- CRISPR/Cas9-Mediated Disruption of ZNF543 Gene: An Approach Toward Discovering Its Relation to TRIM28 Gene in Parkinson’s Disease. (PMID:35467255)
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 543 — Q08ER8 (reviewed: Q08ER8)
All UniProt accessions (1): Q08ER8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_998763* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (24 total): zinc finger region 13, sequence variant 6, chain 1, domain 1, region of interest 1, compositionally biased region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q08ER8-F1 | 69.72 | 0.18 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 41 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CEBPZ_TARGET_GENES, ZNF10_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P, MIR340_5P, MIR6809_3P, MIR338_5P, MIR7110_3P, MIR494_3P, MIR4672, MIR4319, MIR5195_3P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
368 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF543 | GPATCH2L | Q9NWQ4 | 505 |
| ZNF543 | ARMCX5 | Q6P1M9 | 480 |
| ZNF543 | OR4K2 | Q8NGD2 | 480 |
| ZNF543 | OR7G3 | Q8NG95 | 416 |
| ZNF543 | SVOPL | Q8N434 | 399 |
| ZNF543 | A8MYK1 | A8MYK1 | 375 |
| ZNF543 | MRPL23 | Q16540 | 359 |
| ZNF543 | GPR174 | Q9BXC1 | 325 |
| ZNF543 | MYCT1 | Q8N699 | 311 |
| ZNF543 | HIF1AN | Q9NWT6 | 257 |
| ZNF543 | DEFA4 | P12838 | 254 |
| ZNF543 | PTBP3 | O95758 | 247 |
| ZNF543 | RPL23A | P29316 | 243 |
| ZNF543 | RAET1E | Q8TD07 | 241 |
| ZNF543 | SGPL1 | O95470 | 231 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP10-7 | ZNF543 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MCC | ZNF543 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-6 | ZNF543 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF543 | IPO8 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF543 | TRIM24 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF543 | MCC | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF543 | KRTAP10-6 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (22): KRTAP10-7 (Two-hybrid), ZNF543 (Affinity Capture-RNA), ZNF543 (Two-hybrid), KRTAP10-6 (Two-hybrid), ZC3H18 (Affinity Capture-MS), TRIM39 (Affinity Capture-MS), NKTR (Affinity Capture-MS), ZNF445 (Affinity Capture-MS), CENPB (Affinity Capture-MS), UBTF (Affinity Capture-MS), JPH1 (Affinity Capture-MS), ZNF708 (Affinity Capture-MS), FRMD6 (Affinity Capture-MS), KBTBD7 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
133 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 119 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
387 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57323672:A:AG | acceptor_gain | 1.0000 |
| 19:57323673:A:G | acceptor_gain | 1.0000 |
| 19:57323678:CCA:C | acceptor_loss | 1.0000 |
| 19:57323679:CAGG:C | acceptor_loss | 1.0000 |
| 19:57323680:A:AG | acceptor_gain | 1.0000 |
| 19:57323680:AG:A | acceptor_gain | 1.0000 |
| 19:57323680:AGGT:A | acceptor_gain | 1.0000 |
| 19:57323681:G:A | acceptor_loss | 1.0000 |
| 19:57323681:G:GA | acceptor_gain | 1.0000 |
| 19:57323681:GG:G | acceptor_gain | 1.0000 |
| 19:57323681:GGT:G | acceptor_gain | 1.0000 |
| 19:57323681:GGTG:G | acceptor_gain | 1.0000 |
| 19:57323681:GGTGT:G | acceptor_gain | 1.0000 |
| 19:57323769:G:GT | donor_gain | 1.0000 |
| 19:57323804:TCTGG:T | donor_gain | 1.0000 |
| 19:57323805:CTGG:C | donor_gain | 1.0000 |
| 19:57323806:TGG:T | donor_gain | 1.0000 |
| 19:57323807:GG:G | donor_gain | 1.0000 |
| 19:57323807:GGG:G | donor_gain | 1.0000 |
| 19:57323808:GG:G | donor_gain | 1.0000 |
| 19:57323809:G:GG | donor_gain | 1.0000 |
| 19:57326617:T:TA | acceptor_gain | 1.0000 |
| 19:57326625:A:AG | acceptor_gain | 1.0000 |
| 19:57326625:AT:A | acceptor_gain | 1.0000 |
| 19:57326626:T:G | acceptor_gain | 1.0000 |
| 19:57326626:T:TA | acceptor_gain | 1.0000 |
| 19:57326629:A:AG | acceptor_gain | 1.0000 |
| 19:57326629:ACAG:A | acceptor_gain | 1.0000 |
| 19:57326630:C:G | acceptor_gain | 1.0000 |
| 19:57326631:A:AC | acceptor_loss | 1.0000 |
AlphaMissense
3984 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:57328840:T:C | F460L | 0.997 |
| 19:57328842:T:A | F460L | 0.997 |
| 19:57328842:T:G | F460L | 0.997 |
| 19:57329008:T:C | F516L | 0.997 |
| 19:57329010:T:A | F516L | 0.997 |
| 19:57329010:T:G | F516L | 0.997 |
| 19:57328336:T:C | F292L | 0.996 |
| 19:57328338:C:A | F292L | 0.996 |
| 19:57328338:C:G | F292L | 0.996 |
| 19:57328420:T:C | F320L | 0.996 |
| 19:57328422:T:A | F320L | 0.996 |
| 19:57328422:T:G | F320L | 0.996 |
| 19:57328924:T:C | F488L | 0.996 |
| 19:57328926:C:A | F488L | 0.996 |
| 19:57328926:C:G | F488L | 0.996 |
| 19:57328504:T:C | F348L | 0.995 |
| 19:57328506:C:A | F348L | 0.995 |
| 19:57328506:C:G | F348L | 0.995 |
| 19:57328672:T:C | F404L | 0.995 |
| 19:57328674:C:A | F404L | 0.995 |
| 19:57328674:C:G | F404L | 0.995 |
| 19:57328756:T:C | F432L | 0.995 |
| 19:57328758:C:A | F432L | 0.995 |
| 19:57328758:C:G | F432L | 0.995 |
| 19:57328859:T:C | L466P | 0.995 |
| 19:57329092:T:C | F544L | 0.995 |
| 19:57329094:T:A | F544L | 0.995 |
| 19:57329094:T:G | F544L | 0.995 |
| 19:57328252:T:C | F264L | 0.994 |
| 19:57328254:T:A | F264L | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000102991 (19:57323784 A>G), RS1000267660 (19:57327058 G>A), RS1000293496 (19:57321186 C>T), RS1000324093 (19:57321401 C>T), RS1000432277 (19:57321332 C>T), RS1000613469 (19:57326968 A>C), RS1001167072 (19:57329910 C>T), RS1001207294 (19:57321078 G>A), RS1001490355 (19:57331215 C>T), RS1001675182 (19:57326037 T>C), RS1001720153 (19:57323954 C>T), RS1002147009 (19:57326290 G>A,T), RS1002370782 (19:57331010 C>T), RS1002854714 (19:57320112 T>C), RS1002908478 (19:57320311 G>C,T)
Disease associations
OMIM: gene MIM:616847 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | decreases reaction, affects binding | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | affects cotreatment, increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Cisplatin | decreases expression, affects cotreatment | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Methotrexate | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression, affects cotreatment | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Lactic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.